(Q47968718)

7 February 2018

title

Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response. (English)

1 reference

7 February 2018

1 reference

5

Alter HJ

1 reference

7 February 2018

author name string

Quinnan GV Jr

1

1 reference

7 February 2018

Zhang PF

2

1 reference

7 February 2018

Fu DW

3

1 reference

7 February 2018

Dong M

4

1 reference

7 February 2018

publication date

1 April 1999

1 reference

7 February 2018

AIDS Research and Human Retroviruses

published in

1 reference

7 February 2018

volume

15

1 reference

7 February 2018

issue

6

1 reference

7 February 2018

page(s)

561-570

1 reference

7 February 2018

Identification of a major co-receptor for primary isolates of HIV-1

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/381661A0

Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Crystal structure of the principal neutralization site of HIV-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

ETS family proteins activate transcription from HIV-1 long terminal repeat

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Preparation and characterization of human HIV type 1 neutralizing reference sera

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Lack of correlation between V3 amino acid sequence and syncytium-inducing capacity of some HIV type 1 isolates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Origin of the HIV-susceptible human CD4+ cell line H9

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Fidelity of Thermococcus litoralis DNA polymerase (Vent) in PCR determined by denaturing gradient gel electrophoresis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Extent of antigenic diversity in the V3 region of the surface glycoprotein, gp120, of human immunodeficiency virus type 1 group M and consequences for serotyping

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Evolution of neutralizing antibody response against HIV type 1 virions and pseudovirions in multicenter AIDS cohort study participants

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Packaging system for rapid production of murine leukemia virus vectors with variable tropism

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodies.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1089/088922299311088

Identifiers

DOI

10.1089/088922299311088

1 reference

7 February 2018

PubMed ID

10221533

1 reference

7 February 2018